Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 584, 333-334 (2020)


Updates & Corrections

  • Correction 12 August 2020: An earlier version of this story incorrectly said that the median price for antibody therapies in the United States is US$15,000–$200,000 per treatment. In fact, this is the cost per year of treatment.


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links